Ignite Creation Date:
2024-05-06 @ 8:10 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06288204
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-30
First Post:
2024-02-23
Brief Title:
Green Propolis Extract and Royal Jelly in Hypertensive Patients andor With Chronic Kidney Disease
Sponsor:
Universidade Federal Fluminense
Organization:
Universidade Federal Fluminense
Study Overview
Official Title:
Association of Green Propolis Extract and Royal Jelly to Modulate Inflammation and Oxidative Stress in Hypertensive Patients andor With Chronic Kidney Disease
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This work aims to evaluate the effects of the association of green propolis extract with royal jelly on inflammation and oxidative stress in participants with chronic kidney diseases CKD and Systemic arterial hypertension SAH in a longitudinal randomized double-blind placebo-controlled clinical trial that will be carried out for 2 months
Detailed Description:
Propolis and royal jelly are bee products Propolis is a resinous mixture produced by bees with their saliva and the addition of wax from exudates collected from buds and plant sap Royal jelly is a substance produced in the hypopharyngeal glands of young worker bees Both products are rich in bioactive compounds such as polyphenols The combination of propolis extract and royal jelly substances constituted by the combination of several chemical components with potential biological activity may emerge as a promising adjuvant therapeutic alternative for patients with CKD and SAH
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None